CHPA and FDA in talks on OTC monograph fees

18 July 2016 - Deborah Wilkes

Archived

The US Consumer Healthcare Products Association (CHPA) is having "detailed talks" with the Food and Drug Administration (FDA) about a potential user-fee programme for OTC monograph drugs.

Click tags below for more information on topics:

FDA CHPA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: